An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
Top results in this bookTable of Contents
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Adjunctive Devices for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention [Internet].
Sobieraj DM, White CM, Kluger J, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Dec. (Comparative Effectiveness Reviews, No. 42.)
Endotext [Internet].
Feingold KR, Anawalt B, Blackman MR, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Primary Angioplasty: A Practical Guide [Internet].
Watson TJ, Ong PJL, Tcheng JE, editors.
Singapore: Springer; 2018.
Inflammatory Atherosclerosis: Characteristics of the Injurious Agent.
Frink RJ.
Sacramento (CA): Heart Research Foundation; 2002.
Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease [Internet].
Michos ED, Berger Z, Yeh HC, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Aug. (Comparative Effectiveness Review, No. 135.)
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Point-of-Care Troponin Testing in Patients With Symptoms Suggestive of Acute Coronary Syndrome: A Health Technology Assessment [Internet].
Ho C, Cimon K, Weeks L, et al.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Mar. (CADTH Optimal Use Report, No. 5.1b.)
Diagnostic Accuracy of Screening and Treatment of Post–Acute Coronary Syndrome Depression: A Systematic Review [Internet].
Williams JW Jr, Nieuwsma JA, Namdari N, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Nov. (Comparative Effectiveness Reviews, No. 200.)
High-Sensitivity Cardiac Troponin for the Rapid Diagnosis of Acute Coronary Syndrome in the Emergency Department: A Clinical and Cost-Effectiveness Evaluation [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Mar. (CADTH Optimal Use Report, No. 2.1A.)
Noninvasive Testing for Coronary Artery Disease [Internet].
Skelly AC, Hashimoto R, Buckley DI, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Mar. (Comparative Effectiveness Reviews, No. 171.)
Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease [Internet].
Bravata DM, McDonald KM, Gienger AL, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Oct. (Comparative Effectiveness Reviews, No. 9.)
Screening for Intermediate Risk Factors for Coronary Heart Disease [Internet].
Helfand M, Buckley D, Fleming C, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2009 Oct. (Evidence Syntheses, No. 73.)
Screening Asymptomatic Adults for Coronary Heart Disease With Resting or Exercise Electrocardiography: Systematic Review to Update the 2004 U.S. Preventive Services Task Force Recommendation [Internet].
Chou R, Arora B, Dana T, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep. (Evidence Syntheses, No. 88.)
Clinical Review Report: Ticagrelor (Brilinta) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Aug.
Future Research Needs for the Comparison of Percutaneous Coronary Interventions with Bypass Graft Surgery in Nonacute Coronary Artery Disease: Identification of Future Research Needs from Comparative Effectiveness Review No. 9 [Internet].
Trikalinos TA, Dahabreh IJ, Wong J, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 Sep. (Future Research Needs Papers, No. 1.)
Madame Curie Bioscience Database [Internet].
Austin (TX): Landes Bioscience; 2000-2013.
Clinical Review Report: Rivaroxaban (Xarelto): Bayer Inc. Indication: In combination with 75 mg to 100 mg acetylsalicylic acid, for the prevention of stroke, myocardial infarction, and cardiovascular death, and for the prevention of acute limb ischemia and mortality in patients with coronary artery disease with or without peripheral artery disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jan.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on